OÑATE OCAÑA, LUIS FERNANDO

OÑATE OCAÑA, LUIS FERNANDO

INVESTIGACIÓN MÉDICA · Nivel 3

cancer surgical oncology

Desde 2023 es Subdirector de Investigación Clínica en Instituto Nacional de Cancerología

Perfil académico

Nombre LUIS FERNANDO OÑATE OCAÑA
Área MEDICINA Y CIENCIAS DE LA SALUD
Campo INVESTIGACIÓN MÉDICA
Disciplina CIRUGÍA ONCOLÓGICA
Especialidad ONCOLOGIA, QUIMIOTERAPIA, CIRUGIA ONCOLOGIA
CVU 20591
Institución
Dependencia DIVISION DE INVESTIGACION CLINICA
Entidad CIUDAD DE MEXICO
Nivel 3
Vigencia Inicio: 01/01/2024
Fin: 31/12/2028

Publicaciones ORCID

2026
Comparison of Two Instruments to Assess the Impact of Cachexia on Quality of Life in Women with Cervical Cancer Nutrition and Cancer
The meaning of “p-value”: Pursuing clinical and statistical significance. A narrative review Revista de Investigación Clínica
2025
Prognostic nutritional index as a predictor of surgical complications in women with gynecological cancer International Journal of Gynecological Cancer
Prognostic role of the BRAF V600E variant in the preoperative biopsy in differentiated thyroid cancer Journal of Endocrinological Investigation
Prognostic Nutritional Index is a valuable preoperative prognostic biomarker in Mexican patients surgically intervened on gastrointestinal stromal tumors: a retrospective cohort study Supportive Care in Cancer
Real-world data on the clinical features, therapy patterns, and outcomes of older adults with diffuse large B-cell lymphoma in Latin America: A study from the Grupo de Estudio Latinoamericano de Linfoproliferativos (GELL) Journal of Geriatric Oncology
2024
Peripherical Blood hsa-miR-335-5p Quantification as a Prognostic, but Not Diagnostic, Marker of Gastric Cancer Diagnostics
Mexican validation of the QLQ-INFO25 instrument to measure satisfaction with the received information in patients with gastrointestinal carcinoma
Early Incorporation to Palliative Care (EPC) in Patients With Advanced Non-Small Cell Lung Cancer: The PACO Randomized Clinical Trial Oncologist
Prognostic Nutritional Index is a valuable prognostic marker in Mexican patients operated on and not on gastrointestinal stromal tumors. A retrospective cohort study Research Square